Anika Therapeutics Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) Analysis

Anika Therapeutics, Inc. (ANIK)

14.13 -0.15 (-1.05%) USD | NASDAQ | Mar 30, 16:00

14.13 0.00 (0.00%) After-Hours: 06:13

View Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) for ANIK.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) Benchmarks

Start Trial

BioCryst Pharmaceuticals, Inc.	Upgrade
Lantheus Holdings, Inc.	Upgrade
TELA Bio, Inc.	Upgrade
Plus Therapeutics, Inc.	Upgrade
BioStem Technologies, Inc.	Upgrade